Mehul Joshi
Director of Finance/CFO chez PULMONX CORPORATION
Profil
Mr. Mehul Joshi is a Chief Financial & Accounting Officer at Pulmonx Corp.
Mr. Joshi was previously employed as a Chief Financial Officer by Berkeley Lights, Inc., a Chief Financial & Accounting Officer by PhenomeX, Inc., and a Senior Vice President-Finance, Head-Global FP&A by ResMed, Inc. He received his undergraduate degree from Rutgers State University of New Jersey and an MBA from Rutgers State University of New Jersey.
Postes actifs de Mehul Joshi
| Sociétés | Poste | Début |
|---|---|---|
| PULMONX CORPORATION | Director of Finance/CFO | 03/04/2024 |
Anciens postes connus de Mehul Joshi
| Sociétés | Poste | Fin |
|---|---|---|
| BRUKER CELLULAR ANALYSIS, INC. | Director of Finance/CFO | 02/10/2023 |
| RESMED, INC. | Corporate Officer/Principal | 01/07/2022 |
Berkeley Lights, Inc.
 Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | Director of Finance/CFO | - |
Formation de Mehul Joshi
| Rutgers State University of New Jersey | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| RESMED, INC. | Health Technology |
| PULMONX CORPORATION | Health Technology |
| Entreprise privées | 2 |
|---|---|
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | Technology Services |
PhenomeX, Inc.
 PhenomeX, Inc. Packaged SoftwareTechnology Services Bruker Cellular Analysis, Inc. is a biology company that engages in the study of cells. Its tools and services allow the prevention and treatment of disease. The company was founded in 2011 and is headquartered in Emeryville, CA. | Technology Services |
